anti-Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) Antikörper

The protein encoded by TNFRSF8 is a member of the TNF-receptor superfamily. Zusätzlich bieten wir Ihnen TNFRSF8 Kits (34) und TNFRSF8 Proteine (21) und viele weitere Produktgruppen zu diesem Protein an.

Alle Antikörper anzeigen Gen GeneID UniProt
TNFRSF8 943 P28908
TNFRSF8 21941 Q60846
TNFRSF8 25069 P97525
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top anti-TNFRSF8 Antikörper auf antikoerper-online.de

Showing 10 out of 696 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Anbieter Lieferzeit Preis Details
Human Kaninchen Unkonjugiert WB Anti-CD30 Picoband antibody,  All lanes: Anti-CD30 at 0.5ug/ml Lane 1: HELA Whole Cell Lysate at 40ug Lane 2: 293T Whole Cell Lysate at 40ug Lane 3: JURKAT Whole Cell Lysate at 40ug Predicted bind size: 67KD Observed bind size: 67KD 100 μg Anmelden zum Anzeigen 4 bis 6 Tage
$200.00
Details
Maus Hamster FITC FACS 0.5 mg Anmelden zum Anzeigen 6 bis 8 Tage
$379.50
Details
Human Maus Unkonjugiert EIA, FACS, IHC (fro), IHC (p), IP, WB   0.1 mg Anmelden zum Anzeigen 6 bis 8 Tage
$423.50
Details
Human Maus FITC FACS 50 μg Anmelden zum Anzeigen 6 bis 8 Tage
$346.50
Details
Human Kaninchen Unkonjugiert ELISA, IHC (p), IP, WB 100 μg Anmelden zum Anzeigen 20 bis 21 Tage
$218.90
Details
Maus Ratte PE FACS   100 Tests Anmelden zum Anzeigen 6 bis 8 Tage
$313.50
Details
Maus Hamster Biotin FACS   0.5 mg Anmelden zum Anzeigen 6 bis 8 Tage
$379.50
Details
Human Maus Unkonjugiert FACS, ELISA, WB Figure 1: Red: Control Antigen (100 ng), Purple: Antigen (10ng), Green: Antigen (50 ng), Blue: Antigen (100 ng) Figure 2: Flow cytometric analysis of Hela cells using CD30 mouse mAb (green) and negative control (red) . 100 μL Anmelden zum Anzeigen 2 bis 3 Tage
$430.10
Details
Human Kaninchen FITC IF (p) Raji probed with CD30 Polyclonal Antibody, FITC Conjugated (bs-2495R-FITC) at 1:100 for 30 minutes compared to control cells (blue) and isotype control (orange). 100 μL Anmelden zum Anzeigen 14 bis 21 Tage
$405.90
Details
Human Maus Unkonjugiert FACS, IHC (p) Human Thymus (formalin-fixed, paraffin-embedded) stained with TNFRSF8 antibody LS-B1865 at 5 ug/ml followed by biotinylated anti-mouse IgG secondary antibody LS-D2, alkaline phosphatase-streptavidin and chromogen. 0.1 mg Anmelden zum Anzeigen 5 bis 7 Tage
$242.55
Details

TNFRSF8 Antikörper nach Reaktivität, Anwendung, Klonalität and Konjugat

Attribute Applikationen Wirt Klonalität Konjugat
Human , , , ,
, ,
,
, , , , , , , , , , , , , , , , , , ,
Mouse (Murine) , , , ,
, , ,
,
, , , , , , , , , , , , , , , , , , ,
Rat (Rattus) , ,


, , , , , , , , , , , , ,

Am meisten referenzierte anti-TNFRSF8 Antikörper

  1. Mouse (Murine) Monoclonal TNFRSF8 Primary Antibody für FACS - ABIN2689176 : Amakawa, Hakem, Kundig, Matsuyama, Simard, Timms, Wakeham, Mittruecker, Griesser, Takimoto, Schmits, Shahinian, Ohashi, Penninger, Mak: Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. in Cell 1996 (PubMed)
    Show all 12 Pubmed References

  2. Human Monoclonal TNFRSF8 Primary Antibody für IHC (f), FACS - ABIN2749180 : Aalberse, Kapitein, de Roock, Klein, de Jager, van der Zee, Hoekstra, van Wijk, Prakken: Cord blood CD4+ T cells respond to self heat shock protein 60 (HSP60). in PLoS ONE 2011 (PubMed)
    Show all 5 Pubmed References

  3. Human Monoclonal TNFRSF8 Primary Antibody für IHC (f), FACS - ABIN2749181 : Falini, Pileri, Pizzolo, Dürkop, Flenghi, Stirpe, Martelli, Stein: CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. in Blood 1995 (PubMed)
    Show all 5 Pubmed References

  4. Human Monoclonal TNFRSF8 Primary Antibody für FACS - ABIN610027 : Dayanir, Meyer, Lashkari, Rahimi: Identification of tyrosine residues in vascular endothelial growth factor receptor-2/FLK-1 involved in activation of phosphatidylinositol 3-kinase and cell proliferation. in The Journal of biological chemistry 2001 (PubMed)
    Show all 2 Pubmed References

  5. Human Monoclonal TNFRSF8 Primary Antibody für FACS - ABIN4900897 : Cocco, Stephenson, Care, Newton, Barnes, Davison, Rawstron, Westhead, Doody, Tooze: In vitro generation of long-lived human plasma cells. in Journal of immunology (Baltimore, Md. : 1950) 2012 (PubMed)
    Show all 2 Pubmed References

  6. Human Monoclonal TNFRSF8 Primary Antibody für FACS - ABIN2689175 : Guesdon, Ternynck, Avrameas: The use of avidin-biotin interaction in immunoenzymatic techniques. in The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1979 (PubMed)

  7. Human Monoclonal TNFRSF8 Primary Antibody für FACS, IHC (p) - ABIN192353 : Pavlov, Martins, Delgado: Development and validation of a fluorescent microsphere immunoassay for soluble CD30 testing. in Clinical and vaccine immunology : CVI 2009 (PubMed)
    Show all 7 Pubmed References

  8. Human Monoclonal TNFRSF8 Primary Antibody für FACS, IHC (p) - ABIN192354 : Wright, Rumble, Duckett: CD30 activates both the canonical and alternative NF-kappaB pathways in anaplastic large cell lymphoma cells. in The Journal of biological chemistry 2007 (PubMed)
    Show all 7 Pubmed References

  9. Human Monoclonal TNFRSF8 Primary Antibody für FACS, IHC (p) - ABIN192355 : Zeiser, Nguyen, Hou, Beilhack, Zambricki, Buess, Contag, Negrin: Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease. in Blood 2007 (PubMed)
    Show all 7 Pubmed References

  10. Human Monoclonal TNFRSF8 Primary Antibody für IHC (fro), IF - ABIN2479874 : Lacroix, Collot-Teixeira, Mardivirin, Jaccard, Petit, Piguet, Sturtz, Preux, Bordessoule, Ranger-Rogez: Involvement of human herpesvirus-6 variant B in classic Hodgkin's lymphoma via DR7 oncoprotein. in Clinical cancer research : an official journal of the American Association for Cancer Research 2010 (PubMed)

Weitere Antikörper gegen TNFRSF8 Interaktionspartner

Human Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) Interaktionspartner

  1. Variant histology is common in pediatric NLPHL, especially types C and E, which are associated with IgD expression. Type C variant histology and possibly type D are associated with decreased EFS (zeige EFS Antikörper), but neither IgD nor CD30 are adverse features. Variant histology may warrant increased surveillance, but did not affect overall survival.

  2. Expression of CD30 in patients with both DLBCL and other aggressive B-cell lymphomas and the absence of MYC (zeige MYC Antikörper) oncogene (zeige RAB1A Antikörper)-driven proliferation in the majority of these tumors suggests that brentuximab may be a particularly effective form of targeted therapy in the subset of patients with high CD30 expression.

  3. Prevalence of the CD30 (Ki-1) antigen in human solid tumors was summarized.

  4. CD30 expression was detected in up to 25% of cases of diffuse large B-cell lymphoma and was more frequent in tumors without MYC (zeige MYC Antikörper) rearrangement. CD30 expression was not associated with overall survival in R-EPOCH-treated de novo DLBCL patients.

  5. CD30 facilitates phosphorylation of heat shock factor 1, activates heat shock promoter element, and induces heat shock protein (HSP) 90 (zeige HSP90AA1 Antikörper).

  6. this study shows that polyclonal and allogeneic stimulation induced higher levels of CD30 transcripts in end-stage renal disease patients compared to control patients

  7. CD30 expression was not associated with prognosis in our cohort of de novoDLBCL, including in patients who received aggressive chemotherapy. CD30 expression and MYC (zeige MYC Antikörper) rearrangement were mutually exclusive in de novoDLBCL.

  8. Case Report: CD30 positive lymphomatoid papulosis arising in association with cutaneous amyloidosis in a patient with multiple myeloma.

  9. The heterogeneity of CD30 expression in refractory or relapsed peripheral T-cell lymphoma patients indicates the likelihood for better response for patients with strong CD30 expression by tumor cells.

  10. CD30 may be useful as a prognostic marker in rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP (zeige DDIT3 Antikörper)) treated DLBCLs, indicating favorable outcomes in a Chinese population.

Mouse (Murine) Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) Interaktionspartner

  1. This study demonstrated the amelioration of MOG35-55 peptide-induced active EAE in CD30 KO mice. CD30 was expressed limitedly on CD4 (zeige CD4 Antikörper) T cells at the induction phase of experimental autoimmune encephalomyelitis.

  2. Data indicate that CD30L (zeige TNFSF8 Antikörper)/CD30 axis plays a modulatory role in the pathogenesis of experimental autoimmune encephalomyelitis (EAE).

  3. role in the maintenance and activation of IL-17A (zeige IL17A Antikörper)-producing gammadelta T cells

  4. These results suggest that CD30 signaling plays an important role in the activation of IL-17A (zeige IL17A Antikörper)-producing Vgamma1(-) Vgamma4(-) gammadelta T cells bearing Vgamma6 at an early stage of BCG (zeige SLC11A1 Antikörper) infection.

  5. Interference of the CD30-CD30L (zeige TNFSF8 Antikörper) pathway reduces atherosclerosis development.

  6. CD30L (zeige TNFSF8 Antikörper)/CD30 pathway acts as an accelerator of enteritis in a murine disease model

  7. role of CD30L (zeige TNFSF8 Antikörper)/CD30 interactions in allergic rhinitis; results suggest that CD30L (zeige TNFSF8 Antikörper) plays an important role in allergic rhinitis

  8. Abrogation of CD30 and OX40 (zeige TNFRSF4 Antikörper) signals prevents autoimmune disease in FoxP3 (zeige FOXP3 Antikörper)-deficient mice.

  9. Studies demonstrate that CD30L (zeige TNFSF8 Antikörper)/CD30 signaling executed by the T-T cell interaction plays a critical role in Th17 cell differentiation.

  10. CD30 can signal in a completely TCR-independent fashion to induce IL-13 (zeige IL13 Antikörper) production by effector T cells.

TNFRSF8 Antigen-Profil

Protein Überblick

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is expressed by activated, but not by resting, T and B cells. TRAF2 and TRAF5 can interact with this receptor, and mediate the signal transduction that leads to the activation of NF-kappaB. This receptor is a positive regulator of apoptosis, and also has been shown to limit the proliferative potential of autoreactive CD8 effector T cells and protect the body against autoimmunity. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported.

Genbezeichner und Symbole assoziert mit TNFRSF8

  • TNF receptor superfamily member 8 (TNFRSF8) Antikörper
  • tumor necrosis factor receptor superfamily, member 8 (Tnfrsf8) Antikörper
  • TNF receptor superfamily member 8 (Tnfrsf8) Antikörper
  • TNF superfamily member 8 (TNFSF8) Antikörper
  • Cd30 Antikörper
  • D1S166E Antikörper
  • Ki Antikörper
  • Ki-1 Antikörper
  • TNFRSF8 Antikörper

Bezeichner auf Proteinebene für TNFRSF8

CD30L receptor , Ki-1 antigen , cytokine receptor CD30 , lymphocyte activation antigen CD30 , tumor necrosis factor receptor superfamily member 8 , Tumor necrosis factor superfamily member 8 , tumor necrosis factor superfamily, member CD30 , tumor necrosis factor receptor superfamily, member 8 , tumor necrosis factor ligand superfamily member 8 , tumor necrosis factor receptor superfamily member 8-like

GENE ID SPEZIES
943 Homo sapiens
21941 Mus musculus
25069 Rattus norvegicus
395090 Gallus gallus
457960 Pan troglodytes
487438 Canis lupus familiaris
574055 Sus scrofa
574056 Bos taurus
614780 Bos taurus
722773 Macaca mulatta
100385465 Callithrix jacchus
100579424 Nomascus leucogenys
Ausgewählte Anbieter für anti-TNFRSF8 (TNFRSF8) Antikörper
Haben Sie etwas anderes gesucht?